<?xml version="1.0" ?>
<document id="d71c2fa8fe1c3df75d031c50267993ede529b85c">
  <chunk id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c0" text="The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity">
    <entity charOffset="99-115" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c0.e0" ontology_id="GO_0016579" text="deubiquitination" type="gene_function"/>
  </chunk>
  <chunk id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1" text="Background: The outcome of a viral infection is regulated by complex interactions of viral and host factors. SARS coronavirus (SARS-CoV) engages and regulates several innate immune response pathways during infection. We have previously shown that the SARS-CoV Papain-like Protease (PLpro) inhibits type I interferon (IFN) by inhibiting IRF3 phosphorylation thereby blocking downstream Interferon induction. This finding prompted us to identify other potential mechanisms of inhibition of PLpro on IFN induction. Methods: We have used plasmids expressing PLpro and IRF3 including an IRF3 mutant that is constitutively active, called IRF3(5D). In these experiments we utilize transfections, chromatin immunoprecipitation, Electro-mobility Shift Assays (EMSA) and protein localization to identify where IRF3 and IRF3(5D) are inhibited by PLpro. Results: Here we show that PLpro also inhibits IRF3 activation at a step after phosphorylation and that this inhibition is dependent on the de-ubiquitination (DUB) activity of PLpro. We found that PLpro is able to block the type I IFN induction of a constitutively active IRF3, but does not inhibit IRF3 dimerization, nuclear localization or DNA binding. However, inhibition of PLpro's DUB activity by mutagenesis blocked the IRF3 inhibition activity of PLpro, suggesting a role for IRF3 ubiquitination in induction of a type I IFN innate immune response. Conclusion: These results demonstrate an additional mechanism that PLpro is able to inhibit IRF3 signaling. These data suggest novel innate immune antagonism activities of PLpro that may contribute to SARS-CoV pathogenesis.">
    <entity charOffset="29-44" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e0" ontology_id="GO_0016032" text="viral infection" type="gene_function"/>
    <entity charOffset="167-189" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e1" ontology_id="GO_0045087" text="innate immune response" type="gene_function"/>
    <entity charOffset="174-189" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e2" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
    <entity charOffset="341-356" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e3" ontology_id="GO_0016310" text="phosphorylation" type="gene_function"/>
    <entity charOffset="689-698" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e4" ontology_id="GO_0000785" text="chromatin" type="gene_function"/>
    <entity charOffset="761-781" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e5" ontology_id="GO_0008104" text="protein localization" type="gene_function"/>
    <entity charOffset="769-781" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e6" ontology_id="GO_0051179" text="localization" type="gene_function"/>
    <entity charOffset="921-936" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e7" ontology_id="GO_0016310" text="phosphorylation" type="gene_function"/>
    <entity charOffset="1168-1180" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e8" ontology_id="GO_0051179" text="localization" type="gene_function"/>
    <entity charOffset="1374-1396" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e9" ontology_id="GO_0045087" text="innate immune response" type="gene_function"/>
    <entity charOffset="1381-1396" id="d71c2fa8fe1c3df75d031c50267993ede529b85c.c1.e10" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
  </chunk>
</document>
